GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,474.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 1,609.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,068.16m
  • Volume: 1,909,613
  • Market Cap: £59,965m
  • RiskGrade: 129
  • Beta: 0.02

Latest ShareCast News

GSK plans $30bn US investment as pharma faces tariff threat

By Frank Prenesti

Date: Wednesday 17 Sep 2025

(Sharecast News) - GSK has announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years, amid fears of tariffs being imposed on the pharma industry by US President Donald Trump, who is in the UK on a state visit.

GSK ShareCast News

GSK gepotidacin edges closer to landmark approva... 11-Aug-2025 ShareCast
GSK and CureVac secure $740m payout in mRNA pate... 08-Aug-2025 ShareCast
London close: Stocks fall on Trump's latest tari... 01-Aug-2025 ShareCast
London close: Stocks mixed on robust US data, ea... 30-Jul-2025 ShareCast
GSK Q2 revenues grow, expects FY performance to ... 30-Jul-2025 ShareCast

GSK Regulatory News

GSK US Investment Announcement 17-Sep-2025 07:00 RNS
Transaction in Own Shares 17-Sep-2025 07:00 RNS
Transaction in Own Shares 16-Sep-2025 07:00 RNS
Transaction in Own Shares 15-Sep-2025 07:00 RNS
Transaction in Own Shares 12-Sep-2025 07:00 RNS

GSK Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,474.00p
Change Today 11.00p
% Change 0.75 %
52 Week High 1,609.50
52 Week Low 1,264.00
Volume 1,909,613
Shares Issued 4,068.16m
Market Cap £59,965m
Beta 0.02
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 14
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for 17-Sep-2025

Time Volume / Share Price
14:57 84 @ 1,473.73p
14:57 1,182 @ 1,474.00p
14:57 556 @ 1,474.00p
14:56 15 @ 1,473.00p
14:56 5 @ 1,473.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page